432 related articles for article (PubMed ID: 37204441)
1. Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.
Schlesinger S; Lang A; Christodoulou N; Linnerz P; Pafili K; Kuss O; Herder C; Neuenschwander M; Barbaresko J; Roden M
Diabetologia; 2023 Aug; 66(8):1395-1412. PubMed ID: 37204441
[TBL] [Abstract][Full Text] [Related]
2. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.
Schlesinger S; Neuenschwander M; Lang A; Pafili K; Kuss O; Herder C; Roden M
Diabetologia; 2021 Jul; 64(7):1480-1491. PubMed ID: 33907860
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroids for the treatment of COVID-19.
Griesel M; Wagner C; Mikolajewska A; Stegemann M; Fichtner F; Metzendorf MI; Nair AA; Daniel J; Fischer AL; Skoetz N
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD015125. PubMed ID: 35262185
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.
Mahamat-Saleh Y; Fiolet T; Rebeaud ME; Mulot M; Guihur A; El Fatouhi D; Laouali N; Peiffer-Smadja N; Aune D; Severi G
BMJ Open; 2021 Oct; 11(10):e052777. PubMed ID: 34697120
[TBL] [Abstract][Full Text] [Related]
6. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
7. Drug treatments for covid-19: living systematic review and network meta-analysis.
Siemieniuk RA; Bartoszko JJ; Zeraatkar D; Kum E; Qasim A; Martinez JPD; Izcovich A; Lamontagne F; Han MA; Agarwal A; Agoritsas T; Azab M; Bravo G; Chu DK; Couban R; Devji T; Escamilla Z; Foroutan F; Gao Y; Ge L; Ghadimi M; Heels-Ansdell D; Honarmand K; Hou L; Ibrahim Q; Khamis A; Lam B; Mansilla C; Loeb M; Miroshnychenko A; Marcucci M; McLeod SL; Motaghi S; Murthy S; Mustafa RA; Pardo-Hernandez H; Rada G; Rizwan Y; Saadat P; Switzer C; Thabane L; Tomlinson G; Vandvik PO; Vernooij RW; Viteri-GarcÃa A; Wang Y; Yao L; Zhao Y; Guyatt GH; Brignardello-Petersen R
BMJ; 2020 Jul; 370():m2980. PubMed ID: 32732190
[TBL] [Abstract][Full Text] [Related]
8. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
9. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
Richter B; Hemmingsen B; Metzendorf MI; Takwoingi Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012661. PubMed ID: 30371961
[TBL] [Abstract][Full Text] [Related]
10. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
11. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
[TBL] [Abstract][Full Text] [Related]
12. Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis.
Li C; Islam N; Gutierrez JP; Lacey B; Moolenaar RL; Richter P
BMJ Open; 2021 Nov; 11(11):e051711. PubMed ID: 34836901
[TBL] [Abstract][Full Text] [Related]
13. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.
Treskova-Schwarzbach M; Haas L; Reda S; Pilic A; Borodova A; Karimi K; Koch J; Nygren T; Scholz S; Schönfeld V; Vygen-Bonnet S; Wichmann O; Harder T
BMC Med; 2021 Aug; 19(1):212. PubMed ID: 34446016
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
16. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
17. Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.
Schlesinger S; Neuenschwander M; Barbaresko J; Lang A; Maalmi H; Rathmann W; Roden M; Herder C
Diabetologia; 2022 Feb; 65(2):275-285. PubMed ID: 34718834
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against covid-19: living systematic review and network meta-analysis.
Bartoszko JJ; Siemieniuk RAC; Kum E; Qasim A; Zeraatkar D; Martinez JPD; Azab M; Ibrahim S; Izcovich A; Soto GB; Roldan Y; Agarwal A; Agoritsas T; Chu DK; Couban R; Devji T; Foroutan F; Ghadimi M; Honarmand K; Khamis A; Lamontagne F; Loeb M; McLeod SL; Motaghi S; Murthy S; Mustafa RA; Rochwerg B; Switzer C; Thabane L; Vandvik PO; Vernooij RWM; Wang Y; Yao L; Guyatt GH; Brignardello-Petersen R
BMJ; 2021 Apr; 373():n949. PubMed ID: 33903131
[TBL] [Abstract][Full Text] [Related]
19. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
20. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
